Beyond Approval: Why Your Oncology Label Determines Commercial Success
A recent Pharmaceutical Executive article explores how in today’s restrictive oncology landscape, securing FDA approval is no longer enough—biopharma companies must strategically optimize their drug labels from early development through launch to ensure payer access, reimbursement, and commercial success.
In an article for Applied Clinical Trials, Gaurav Bhatnagar, chief growth officer, Tilda Research, examines how clinical research remains trapped in outdated 1970s-era processes and argues that AI-powered “teammates” can finally deliver the long-promised transformation—cutting trial costs and timelines, improving data quality, and expanding access for investigators and patients alike.
Publication Bias—as Old as Science Itself?
Publication bias—favoring the dissemination of positive over negative or inconclusive results—has long distorted the scientific record, and in clinical research, it can mislead evidence-based decisions by overstating benefits and underrepresenting risks, underscoring the need for greater transparency and critical appraisal of the full body of evidence.
Q&A: How IQVIA Keeps Pharmacists Engaged with US Prescription Drug Use
In an interview with Drug Topics, IQVIA’s Michael Kleinrock discusses the 2025 Understanding the Use of Medicines in the US report, highlighting how emerging trends—such as the growth of obesity and diabetes drugs, shifts in oncology spending, and rising volumes in immunology and rare disease treatments—help pharmacists stay informed and engaged in a rapidly evolving healthcare landscape.
After Three Strikes, Relmada Abandons Depression Drug Esmethadone
Relmada Therapeutics has officially discontinued development of its depression drug esmethadone after a series of failed Phase III trials, marking the end of a years-long effort and prompting the company to shift its focus to oncology assets following the termination of its original licensing agreement.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.